ADC CDMO业绩及订单盘点:药明合联、东曜药业、皓元医药

生物药大时代
Sep 22

▲11月6-7日 第十届广州(大湾区)生物医药创新者峰会扫码报名声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议近年来,全球ADC药物研发进展迅速,中国企业尤其活跃。据GlobalData最新报告,2025年全球ADC市场规模预计突破300亿美元,较五年前增长近3倍。仅2025年上半年,全球就有12...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10